Shema Oral Liquid Ameliorates the Severity of LPS-Induced COPD via Regulating DNMT1

Background: Chronic obstructive pulmonary disease (COPD) is the most common respiratory disease with high morbidity and mortality. Shema oral liquid (Shema) is a traditional Chinese medicine (TCM) approved for the treatment of respiratory diseases. Clinical applications have shown that Shema has ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Fangbo, Guo, Feifei, Liu, Yang, Zhang, Yi, Li, Defeng, Yang, Hongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214040/
https://www.ncbi.nlm.nih.gov/pubmed/35754478
http://dx.doi.org/10.3389/fphar.2022.903593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214040/
https://www.ncbi.nlm.nih.gov/pubmed/35754478
http://dx.doi.org/10.3389/fphar.2022.903593

Ejemplares similares